M Lusky

Author PubWeight™ 72.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature 1981 13.89
2 Characterization of the bovine papilloma virus plasmid maintenance sequences. Cell 1984 5.01
3 Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors. J Virol 1985 4.74
4 Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol 1983 4.56
5 Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci U S A 1993 2.95
6 Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci U S A 1993 2.74
7 Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell 1986 2.58
8 Transient replication of bovine papilloma virus type 1 plasmids: cis and trans requirements. Proc Natl Acad Sci U S A 1986 2.49
9 Effect of repetitive imaging on topographic measurements of the optic nerve head. Arch Ophthalmol 1993 2.40
10 Expression of two proteins from overlapping and oppositely oriented genes on transposable DNA insertion element IS5. Nature 1982 2.39
11 Functional analysis of the replicator structure of lambdoid bacteriophage DNAs. Cold Spring Harb Symp Quant Biol 1979 2.18
12 A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state. J Virol 1986 1.74
13 Induction of structural changes in the bovine papillomavirus type 1 origin of replication by the viral E1 and E2 proteins. Proc Natl Acad Sci U S A 1994 1.65
14 The bovine papillomavirus replicon. Ciba Found Symp 1986 1.22
15 Amplification of a bovine papillomavirus-simian virus 40 chimera. J Virol 1985 1.12
16 Inceptor and origin of DNA replication in lambdoid coliphages. I. The lambda DNA minimal replication system. Gene 1979 1.11
17 Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol 1993 1.08
18 Two DNA-bound E2 dimers are required for strong transcriptional activation and for cooperation with cellular factors in most cells. New Biol 1991 1.06
19 Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther 2002 1.04
20 Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol Lett 1997 1.04
21 Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum Gene Ther 2000 1.00
22 Short-term effects of levobunolol on ocular pulsatile flow. Am J Ophthalmol 1992 0.98
23 Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. Surv Ophthalmol 1997 0.96
24 A comparison of generalization functions and frame of reference effects in different training paradigms. Percept Psychophys 1992 0.91
25 Age-related changes in the human lens: a comparison of Scheimpflug photography and lens density index. J Cataract Refract Surg 1994 0.87
26 Augmented trabeculectomy in paediatric glaucoma. Br J Ophthalmol 2005 0.85
27 Pupillary block following posterior chamber intraocular lens implantation in adults. Br J Ophthalmol 2003 0.84
28 Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy. Hum Gene Ther 2001 0.83
29 Reproducibility of quantitative anterior chamber angle measurements with scheimpflug video imaging. J Glaucoma 1992 0.82
30 Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies. Cancer Gene Ther 2007 0.80
31 Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Ophthalmic Surg Lasers 2000 0.80
32 Differential influence of the E4 adenoviral genes on viral and cellular promoters. J Gene Med 2001 0.79
33 Pseudophakic and aphakic pupillary block. Ann Ophthalmol 1988 0.79
34 Late visual field changes following cryotherapy for retinopathy of prematurity stage 3. Br J Ophthalmol 1995 0.78
35 Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res 1988 0.78
36 Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death. Endothelium 2001 0.77
37 The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Eye (Lond) 1995 0.76
38 Inceptor and origin of DNA replication in lambdoid coliphages. II. The lambda DNA maximal replication system. Gene 1979 0.76
39 The use of fibrin adhesive in trabeculectomy: a pilot study. Br J Ophthalmol 2006 0.75
40 Gene transfer into canine myoblasts. Cytotechnology 1999 0.75
41 [Visual disturbances in mitral valve prolapse]. Harefuah 1987 0.75
42 Anterior chamber angle configuration before and after iridotomy measured by scheimpflug video imaging. J Glaucoma 1994 0.75
43 [Retinal artery obstruction in young patients]. Harefuah 1986 0.75
44 [Lowering intraocular pressure in glaucoma--by how much?]. Harefuah 1999 0.75
45 Detection of replicational inceptor signals in IS5. Cold Spring Harb Symp Quant Biol 1981 0.75
46 Threshold sensitivity tests in various ocular diseases. Ann Ophthalmol 1989 0.75
47 Implantation growth of an iris melanocytic lesion simulating a ciliary body melanoma. Ophthalmic Surg 1987 0.75
48 Unusual posterior retinal holes associated with high myopia in XYY syndrome. Ann Ophthalmol 1990 0.75
49 The prevalence of retinal detachment in aphakic high myopic patients. Ophthalmic Surg 1987 0.75
50 Ultrasonographic findings of the optic disc in congenital glaucoma. Ophthalmic Surg Lasers 1996 0.75
51 A microtest plate assay of functional excitatory amino acid receptors. J Neurosci Methods 1989 0.75
52 Intravitreal gas injection for hypotony after cataract surgery. J Cataract Refract Surg 1998 0.75